LIGAND PHARMAC.NEW DL-001 financial statements, including revenue, expenses, profit, and loss

The total revenue of LGDN for the last quarter is 46.53 M EUR, and it's 20.02% higher compared to the previous quarter. The net income of Q3 24 is -6.44 M EUR.